E-drug: Re: Double standards in pharmaceutical advertising
----------------------------------------------------------
Here is a list of articles/books/studies that have appeared on this topic
in the past half dozen years. I have also recently reviewed an article
comparing information in the U.S. PDR and the Brazilian equivalent for the
journal Pharmacoepidemiology and Drug Safety and have written an editorial
on the subject to accompany the article.
Joel Lexchin
Dikshit RK, Dikshit N. Commercial source of drug information: comparison
between the United Kingdom and India. BMJ 1994;309:990-1.
Herxheimer A, Lundborg CS, Westerholm B. Advertisements for medicines in
leading medical journals in 18 countries: a 12-month survey of information
content and standards. Int J Health Serv 1993;23:161-72.
Lal A, Moharna AK, Srivastava S. Comparative evaluation of drug
advertisements in Indian, British and American medical journals. J Indian
Med Assoc 1997;95:19-20.
Office of Technology Assessment. Drug labeling in developing countries.
Washington, D.C.: U.S. Congress, 1993.
van Maaren PJM, van Mil JWF, Hardon AP, Haaijer-Ruskamp FM, Dukes MNG.
Dutch drugs in developing countries. Groningen: Styx Publications, 1994.